Announcements Trials
Browse Landscape

Phase

Phase NA 15Phase 3 13Phase 4 6Phase 2 6Phase 2/3 2Phase EARLY_PHASE1 1Phase 1 1

Status

Unknown 3Terminated 2Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 13Neoplasms 10Carcinoma, Non-Small-Cell Lung 10Lung Neoplasms 9Prostatic Neoplasms 7Recurrence 6Neoplasm Metastasis 6Head and Neck Neoplasms 6Carcinoma, Hepatocellular 6Stomach Neoplasms 5Pancreatic Neoplasms 5Colorectal Neoplasms 5Carcinoma, Squamous Cell 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Multiple Myeloma 4Melanoma 4Liver Neoplasms 4Endometrial Neoplasms 4Ovarian Neoplasms 3Myelodysplastic Syndromes 3Lymphoma, Non-Hodgkin 3Lymphoma, Large B-Cell, Diffuse 3Hematologic Neoplasms 3Fatigue 3Esophageal Neoplasms 3Depression 3Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Rectal Neoplasms 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Terminated × Leiomyoma × Clear all
NCT01504308 2017-04-05

SOFIA

Philips Healthcare

Phase 2/3 Terminated
49 enrolled

Leiomyoma, Myofibroma

NCT01786226 2014-09-05

Mifepristone to Treat Uterine Fibroids

Mediterranea Medica S. L.

Phase 2/3 Terminated
220 enrolled

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡